Macadildig, Vicente S.
HRN: 12-59-45 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2022
CEFTAZIDIME 1GM (VIAL)
08/23/2022
08/29/2022
IV
1g
Q8H
Community Acquired Pneumonia - Moderate Risk
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes